Skip to content
Sora Lifesciences
Global medical devices company

Market entry strategy for value-segment hearing aids in India

A global medical devices company sought to assess the opportunity in India’s value-segment (sub-INR 25,000) hearing aid market and define a practical go-to-market strategy to reach under-served patients with affordable digital devices.

Key offerings in this project
  • Market Sizing/Market Potential Assessment
  • GTM Where-to-Play and How-to-Win Strategy
  • Value Proposition/ Concept Testing

The brief

  • Size the value-segment (sub-INR 25,000) hearing aid opportunity in India and its growth trajectory.
  • Understand demand drivers, adoption barriers, and patient personas across income groups.
  • Map the commercial chain and identify the most effective channels to reach under-served patients.
  • Validate low-cost digital device concepts, price thresholds, and prescriber willingness.

The problem

A highly under-penetrated, fragmented value segment with low awareness, unclear demand, and a complex multi-stakeholder purchase pathway

Our approach

Market sizing and landscape analysis combined with in-depth interviews across the commercial chain and product concept testing

  • Sized the value segment and mapped pricing bands, growth, and competitive share across key players.
  • Conducted in-depth interviews across the commercial chain — ENTs, GPs, audiologists, and NGO/charity trusts.
  • Mapped the patient journey and income-based personas to pinpoint adoption drivers and barriers.
  • Ran product concept tests on low-cost digital devices to assess willingness-to-use, price thresholds, and margins.

Key outcomes

Delivered a go-to-market roadmap with product-price-channel fit and actionable market-creation opportunities for affordable hearing aids

  • Value-segment market sizing with pricing-band, competitive-share, and growth breakdown.
  • Commercial-chain assessment detailing the role, attitude, and influence of ENTs, GPs, audiologists, and NGOs.
  • Product concept test results with willingness-to-prescribe and optimal price points by device.
  • Prioritized GTM strategy across public sector, NGO, GP, and outreach channels with product-price recommendations.
Get in touch

Facing a similar challenge?

Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.

© 2026 Sora Life Sciences. All rights reserved.